4//SEC Filing
MIDDLEKAUFF W BRADFORD 4
Accession 0001127602-19-011932
CIK 0001472091other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:50 PM ET
Size
11.7 KB
Accession
0001127602-19-011932
Insider Transaction Report
Form 4
MIDDLEKAUFF W BRADFORD
Senior VP, GC and Secretary
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-03-15−49,766→ 0 total→ Common Stock (49,766 underlying) - Exercise/Conversion
Common Stock
2019-03-15+49,766→ 59,766 total
Holdings
- 14,004.09(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Vesting of RSUs granted to the Reporting Person on August 14, 2018.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- [F3]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- [F4]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001214501
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:50 PM ET
- Size
- 11.7 KB